Hormone Therapy FGF Tyrosine Kinase Inhibitors Cyclin Dependent Kinase Inhibitors Serine-Threonine Kinase Inhibitors CD Protein Inhibitors Other Epigenetics | Breast Cancer | Lung Non-Small Cell Squamous Cancer | HER2 Negative Breast Cancer | HER2 Positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Gastric Cancer | Bladder Cancer | Non Small Cell Lung Cancer | Lung Cancer | Colorectal Cancer | Estrogen Receptor Positive Breast Cancer | Small Cell Lung Cancer |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ABSK091 | ||||||||||||
infigratinib | ||||||||||||
TKI258 | ||||||||||||
palbociclib + BAY 1163877 | ||||||||||||
futibatinib | ||||||||||||
trastuzumab + pertuzumab | ||||||||||||
trastuzumab | ||||||||||||
pazopanib | ||||||||||||
NBL-001 + BI2536 | ||||||||||||
Debio 1347 | ||||||||||||
M6123 | ||||||||||||
ponatinib | ||||||||||||
eFT226 | ||||||||||||
futibatinib + TAS-117 | ||||||||||||
letrozole | ||||||||||||
afimoxifene | ||||||||||||
PD173074 | ||||||||||||
ABSK091 + NBL-001 + BI2536 | ||||||||||||
Aromatase inhibitor |